Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK)
European Journal of Cancer · 2026
DOI: 10.1016/j.ejca.2026.116252 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Jorge Hernando und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hepatobiliary Pancreatic Cancer and Endocrine Tumors, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Ho…. Hauptthemen laut MEDLINE: Neoplasms, Pyrazoles, Pyrimidines, Protein Kinase Inhibitors. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Bayer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hepatobiliary Pancreatic Cancer and Endocrine Tumors, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain; Neuroendocrine and Endocrine Tumor Tr…
- Medical Oncology, Hospital Universitario Marqués de Valdecilla, IDIVAL, UNICAN, Santander, Spain.
- Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain.
- Department of Medical Oncology, IDIBAPS, Hospital Clínic, Barcelona, Spain.
- Department of Pediatric Hematology and Oncology, Hospital Universitario La Paz, Madrid, Spain.
- Pediatric Oncology/Haematology Unit, Hospital Universitario Cruces & Biobizkaia Health Research Institute, Barakaldo, Spain.
Förderung
- Bayer
Zitieren
APA
Hernando, J., Lopez, C., Garcia-Alvarez, A., Aguín Losada, S., Martínez-Sáez, O., Gonzalez-Perez, C., López-Almaraz, R., Sánchez Morillas, R., Rebollo Liceaga, J., Ferreira Freire, L., Pavon-Mengual, M., Ruiz Vico, M., López-Gómez, M., Morilla, I., Rodríguez-Abreu, D., & Capdevila, J. (2026). Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK). European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116252
Vancouver
Hernando J, Lopez C, Garcia-Alvarez A, Aguín Losada S, Martínez-Sáez O, Gonzalez-Perez C, et al. Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK). European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116252
BibTeX
@article{Hernando2026,
author = {Hernando, Jorge and Lopez, Carlos and Garcia-Alvarez, Alejandro and Aguín Losada, Santiago and Martínez-Sáez, Olga and Gonzalez-Perez, Carlos and López-Almaraz, Ricardo and Sánchez Morillas, Raúl and Rebollo Liceaga, Joseba and Ferreira Freire, Laura and Pavon-Mengual, Miriam and Ruiz Vico, María and López-Gómez, Miriam and Morilla, Idoia and Rodríguez-Abreu, Delvys and Capdevila, Jaume},
title = {Larotrectinib in patients with tropomyosin receptor kinase fusion solid tumors in Spain (SPAINTRK)},
journal = {European Journal of Cancer},
year = {2026},
doi = {10.1016/j.ejca.2026.116252}
}
EUVIMED